- Home
- KYMR vs RNW Comparison
KYMR vs RNW Comparison
Compare KYMR & RNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- RNW
- Stock Information
- Founded
- KYMR 2015
- RNW 2011
- Country
- KYMR United States
- RNW United Kingdom
- Employees
- KYMR N/A
- RNW N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- RNW Electric Utilities: Central
- Sector
- KYMR Health Care
- RNW Utilities
- Exchange
- KYMR Nasdaq
- RNW Nasdaq
- Market Cap
- KYMR 2.2B
- RNW 2.2B
- IPO Year
- KYMR 2020
- RNW N/A
- Fundamental
- Price
- KYMR $29.62
- RNW $6.01
- Analyst Decision
- KYMR Buy
- RNW Strong Buy
- Analyst Count
- KYMR 13
- RNW 1
- Target Price
- KYMR $56.69
- RNW $7.50
- AVG Volume (30 Days)
- KYMR 591.0K
- RNW 826.2K
- Earning Date
- KYMR 05-01-2025
- RNW 02-18-2025
- Dividend Yield
- KYMR N/A
- RNW N/A
- EPS Growth
- KYMR N/A
- RNW N/A
- EPS
- KYMR N/A
- RNW 0.04
- Revenue
- KYMR $47,072,000.00
- RNW $1,006,524,942.00
- Revenue This Year
- KYMR $44.93
- RNW N/A
- Revenue Next Year
- KYMR N/A
- RNW $38.75
- P/E Ratio
- KYMR N/A
- RNW $153.19
- Revenue Growth
- KYMR N/A
- RNW N/A
- 52 Week Low
- KYMR $29.07
- RNW $5.15
- 52 Week High
- KYMR $53.27
- RNW $7.49
- Technical
- Relative Strength Index (RSI)
- KYMR 33.94
- RNW 40.25
- Support Level
- KYMR $29.83
- RNW $6.09
- Resistance Level
- KYMR $35.28
- RNW $6.29
- Average True Range (ATR)
- KYMR 1.79
- RNW 0.16
- MACD
- KYMR -0.20
- RNW 0.01
- Stochastic Oscillator
- KYMR 4.54
- RNW 47.01
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About RNW ReNew Energy Global plc
ReNew Energy Global PLC is a developer and operator of clean energy projects intended to meet India's growing energy needs in an efficient, sustainable and socially responsible manner. The company provides end-to-end solutions in a just and inclusive manner in the areas of clean energy, value-added energy offerings through digitalization, storage, and carbon markets that increasingly are integral to addressing climate change. The company has four reportable segments: wind power and solar power, hydro power and transmission line. It derives maximum revenue from Wind Power segment.